FR2793418B1 - Formulations galeniques d'agents antithrombotiques pour administration sous-cutanee - Google Patents

Formulations galeniques d'agents antithrombotiques pour administration sous-cutanee

Info

Publication number
FR2793418B1
FR2793418B1 FR9905975A FR9905975A FR2793418B1 FR 2793418 B1 FR2793418 B1 FR 2793418B1 FR 9905975 A FR9905975 A FR 9905975A FR 9905975 A FR9905975 A FR 9905975A FR 2793418 B1 FR2793418 B1 FR 2793418B1
Authority
FR
France
Prior art keywords
subcutaneous administration
antithrombotic agents
galenic formulations
galenic
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9905975A
Other languages
English (en)
Other versions
FR2793418A1 (fr
Inventor
Benedicte Roger
Gareth Lewis
Frederic Andre
Alain Cuine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR9905975A priority Critical patent/FR2793418B1/fr
Priority to AU45748/00A priority patent/AU4574800A/en
Priority to PCT/FR2000/001245 priority patent/WO2000067727A1/fr
Publication of FR2793418A1 publication Critical patent/FR2793418A1/fr
Application granted granted Critical
Publication of FR2793418B1 publication Critical patent/FR2793418B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9905975A 1999-05-11 1999-05-11 Formulations galeniques d'agents antithrombotiques pour administration sous-cutanee Expired - Fee Related FR2793418B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9905975A FR2793418B1 (fr) 1999-05-11 1999-05-11 Formulations galeniques d'agents antithrombotiques pour administration sous-cutanee
AU45748/00A AU4574800A (en) 1999-05-11 2000-05-09 Galenic formulations of antithrombotic agents for subcutaneous administration
PCT/FR2000/001245 WO2000067727A1 (fr) 1999-05-11 2000-05-09 Formulations galeniques d'agents antithrombiotques pour administration sous-cutanee

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9905975A FR2793418B1 (fr) 1999-05-11 1999-05-11 Formulations galeniques d'agents antithrombotiques pour administration sous-cutanee

Publications (2)

Publication Number Publication Date
FR2793418A1 FR2793418A1 (fr) 2000-11-17
FR2793418B1 true FR2793418B1 (fr) 2001-07-27

Family

ID=9545447

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9905975A Expired - Fee Related FR2793418B1 (fr) 1999-05-11 1999-05-11 Formulations galeniques d'agents antithrombotiques pour administration sous-cutanee

Country Status (3)

Country Link
AU (1) AU4574800A (fr)
FR (1) FR2793418B1 (fr)
WO (1) WO2000067727A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902550D0 (sv) * 1999-07-02 1999-07-02 Astra Ab New crystalline forms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3356732A (en) * 1966-03-29 1967-12-05 Gen Electric 2-[p-(phenylsulfonyl) phenyl]-1, 3-indanedione and its tautomer
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
CH673395A5 (fr) * 1987-01-30 1990-03-15 Ciba Geigy Ag
US5534270A (en) * 1995-02-09 1996-07-09 Nanosystems Llc Method of preparing stable drug nanoparticles
SE9601556D0 (sv) * 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
FR2761065B1 (fr) * 1997-03-20 2000-03-03 Synthelabo Derives de n-(arginyle)benzenesulfonamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
WO2000067727A1 (fr) 2000-11-16
FR2793418A1 (fr) 2000-11-17
AU4574800A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
IL137652A0 (en) Novel galenic formulations of meloxicam for oral administration
EP1171117A4 (fr) Administration a long terme d'agents pharmacologiquement actifs
FR2808685B1 (fr) Compositions pharmaceutiques pour administration transdermique d'agents anti-inflammatoires
FR2806918B1 (fr) Catheter pour l'administration specifique d'un medicament
NO20020208D0 (no) Flytende sammensetninger for oral administrasjon
EE05123B1 (et) Antiprogestiinsete omadustega ravimite manustamise vahendid
FR08C0004I2 (fr) Composition orale d' une dose pour une libération prolongée
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
MA26842A1 (fr) Amino-acides bicycliques servant d'agents pharmaceutiques
NO20002686D0 (no) Forbedring av Peyronies sykdom
NO992944D0 (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
ZA963584B (en) Nanoparticles for oral administration of pharmaceutical agents of low solubility
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
FR2759585B1 (fr) Formulations pharmaceutiques presentees sous forme seche pour l'administration orale d'un compose ammonium quaternaire cyclique
FR2793418B1 (fr) Formulations galeniques d'agents antithrombotiques pour administration sous-cutanee
NO20003799D0 (no) Innkorporering av kolesterol-senkende midler i konfektdosisformer
FR2793412B1 (fr) Formulations galeniques d'argatroban pour administration sous-cutanee
AU2002322424A8 (en) Novel methods and formulations for administration of active agents
PL347770A1 (en) Composition for the parenteral administration of active agents
HUP0201610A3 (en) Derivatives of 4'-demycarosyl-8a-aza-8a-homotylosin
HU9800623D0 (en) Oral application of "(+)-o-demethyl-tramadol as analgesic active component
FR2803047B1 (fr) Composant hybride d'optocouplage
FR2685204B1 (fr) Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine.
FR2796547B3 (fr) Catheter perfectionne pour l'insemination artificielle des lapines
FR2759584B1 (fr) Composition pharmaceutique pour l'administration orale de composes heterocycliques sous forme ammonium quaternaire

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse